gliclazide brands
11 registered brands containing gliclazide in Zambia.
Gliclazide
PubChem CID 3475Molecular formula: C15H21N3O3S
Gliclazide binds to the β cell sulfonyl urea receptor (SUR1). This binding subsequently blocks the ATP sensitive potassium channels. The binding results in closure of the channels and leads to a resulting decrease in potassium efflux leads to depolarization of the β cells. This opens voltage-dependent calcium channels in the β cell resulting in calmodulin activation, which in turn leads to exocytosis of insulin containing secretorty granules.
Source: PubChem (NCBI) ยท compound 3475
All countries
Kenya
Tanzania
Rwanda
Zambia
Uganda
Malawi
South Africa
Zimbabwe
Nigeria
Ghana
Botswana
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| Diabend tablets Tablet Uncoated |
Bal Pharma | Registered/Compliant | Zambia |
| Dynacaz 30mg MR Tablet Uncoated |
Krka D.d. | Registered/Compliant | Zambia |
| DYNACAZ 60MG MR Modified-release tablet |
Krka | Registered/Compliant | Zambia |
| Dynacaz 90 mg MR Modified-release tablet |
Krka | Registered/Compliant | Zambia |
| Gliclan 80mg tablets Tablet Uncoated |
Fourrts Laboratories | Registered/Compliant | Zambia |
| Gliclan M tablets Tablet Uncoated |
Fourrts Laboratories | Registered/Compliant | Zambia |
| Gliclazide Tablet 40mg Tablet Uncoated |
Medreich Limited | Registered/Compliant | Zambia |
| Glucozid M Tablets Uncoated Tablet |
Medley Pharmaceuticals | Registered/Compliant | Zambia |
| Glucozid Tablets Uncoated Tablet |
Medley Pharmaceuticals | Registered/Compliant | Zambia |
| Ziglic MR 30 Modified-release tablet |
Inventia Healthcare Limited | Registered/Compliant | Zambia |
| Ziglic MR 60 Modified-release tablet |
Inventia Healthcare Limited | Registered/Compliant | Zambia |